TrialScope has recently conducted its Clinical Trial Transparency Leadership Forum, as part of its Transparency Leadership series.
The series is designed to bring leaders in life sciences companies together to discuss and debate current and emerging clinical trial transparency and compliance topics.
Each of the forum programmes are developed around specific topics or themes that are important to compliance leaders.
The December forum included discussions of global disclosure performance. This was highlighted through a presentation by Bioethics International president Jennifer Miller entitled ‘The Good Pharma Scorecard.’
TrialScope chief strategy officer Thomas Wicks also presented findings from TrialScope’s Clinical Trial Disclosure Maturity Model.
The presentations and discussions highlighted the importance of measuring disclosure performance and the marketplace perception of performance, while also noting the challenges that most life sciences companies face when developing global disclosure policies.
TrialScope CEO Mike Forgash said: "TrialScope’s Transparency Leadership Forum was an exceptional event that enabled industry leaders to step away from their desks and talk about important strategic and operational topics that impact clinical trial transparency programmes with industry peers.
"The programme is founded on the idea that these leaders can share their rationales, best practices, and challenges in an intimate setting with the goal of learning and improving existing disclosure performance."
Wicks said: "The Transparency Leadership series provides a unique opportunity for our industry peers to collaborate in a non-competitive environment.
"We purposely design plenty of discussion time into the programme so participants get maximum value from their time together.
"In this forum, we addressed disclosure performance as a collection of important metrics that tell a sponsor’s compliance story.
"We also heard the concern about how that story is viewed by the market and the potential impact it has on brand integrity.
"We plan to offer similar programmes in the New Year and will look to current participants to help us shape the agenda and prioritise discussion topics."